What was Tracon Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2023?

Tracon Pharmaceuticals, Inc. reported cash from operating activities of $3.7 million for fiscal 2023 (the year ended Dec 31, 2023), against -$26.2 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2024.

Tracon Pharmaceuticals, Inc.

Delisted

CIK 1394319fmd_08JJYZ5Z71MGJSSH9XR1WBA0WJManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2013 to Jun 30, 2024, 43 periods

Latest annual · FY2022

Millions

Free cash flow: (26)

Open Financials

Tracon Pharmaceuticals, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

Metric	FY2023	FY2022	Change	Source
Cash from operating activities	$3.7 million	-$26.2 million		10-K 2024-03-05 · proof

What was Tracon Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2023?: Tracon Pharmaceuticals, Inc. reported cash from operating activities of $3.7 million for fiscal 2023 (the year ended Dec 31, 2023), against -$26.2 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1394319&period_type=annual&limit=5"

Information only, not investment advice.